The Zacks Medical sector has modestly outperformed the S&P 500 over the last three months, up more than 7% vs. the general market's 4% gain.
If you are a new investor who has heard about the market's turbulence this year, you might be hesitating to invest at all. Most growth stocks got a beating this year. It would be wise for new investors to diversify their portfolios with some safe stocks along with some growth stocks.
The pharma giant's story won't be over with anticipated sales declines for its top-selling drug.